Skip to content

Clinical trials

Completed Phase 1 Depressive Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Depressive Disorder Phase: Phase 1 Status: Completed Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20041
20067
20076
20085
20097
20102
20121
20141
20154
20172
20184
20192
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed46

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline25
Luye Pharma Group Ltd.3
National Institute of Mental Health (NIMH)3
University of Oxford2
Digestome Therapeutics1
First Affiliated Hospital of Zhejiang University1
Janssen Research & Development, LLC1
Mclean Hospital1
Medical University of South Carolina1
Minneapolis Veterans Affairs Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Depressive Disorder46
Anxiety Disorders12
Major Depressive Disorder8
Mental Disorders5
Mood Disorders5
Depressive Disorder, Treatment-Resistant4
Bipolar Disorder3
Psychotic Disorders2
Schizophrenia2
Stress Disorders, Post-Traumatic2

Trials

Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.